Ceftriaxone Sodium/Tazobactam Sodium

头孢曲松钠/他唑巴坦钠

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCeftriaxone Sodium/Tazobactam Sodium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsPyelonephritisPulmonary Disease, Chronic ObstructiveBronchiectasis +[10] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2009/04/09
Country/TerritoryMainland China
CombinationsYes Ceftriaxone SodiumTazobactam Sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHainan Helpson Medicine & Biotechnique Co LtdHaikou Qili Pharmaceutical Holdings Co LtdWelman (Xiang Bei) Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsPyelonephritisPulmonary Disease, Chronic ObstructiveBronchiectasis +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A